dc.contributor.author |
Valdivia, M. |
|
dc.contributor.author |
Soto Becerra, Percy |
|
dc.contributor.author |
Laguna-Barraza, R. |
|
dc.contributor.author |
Rojas, P.A. |
|
dc.contributor.author |
Reyes-Mandujano, I. |
|
dc.contributor.author |
Gonzáles-Reyes, P. |
|
dc.contributor.author |
Temoche, H. |
|
dc.contributor.author |
Timoteo, O.S. |
|
dc.contributor.author |
Lugo-Martinez, G. |
|
dc.contributor.author |
Calzada-Mendoza, C.C. |
|
dc.contributor.author |
Mezones-Holguin, E. |
|
dc.date.accessioned |
2020-12-14T16:10:22Z |
|
dc.date.available |
2020-12-14T16:10:22Z |
|
dc.date.issued |
2020 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/8837 |
|
dc.description.abstract |
Objective: To evaluate the effect of a herbal preparation containing glucosinolates, phytosterols and citrus flavonoids (supplement) on body weight and metabolic parameters usually impaired by menopause. Methods: A pre-clinical experimental study carried out in twenty-five Swiss strain mice (Mus musculus) randomly distributed (1:1:1:1:1 ratio) to five groups to receive for ten weeks: (1) oral gelatinized maca extract 0.5625 mg/kg/day + bilateral ovariectomy (Maca + OVX); (2) oral supplement 0.5625 mg/kg/day + bilateral ovariectomy (S1 + OVX); (3) oral supplement 1.6875 mg/kg/day + bilateral ovariectomy (S2 + OVX); (4) oral saline 100 µl/kg/day + bilateral ovariectomy (OVX); and (5) oral saline 100 µl/kg/day + sham surgery (sham). The primary endpoint was change in body weight gain from baseline to final. Secondary endpoints were uterine weight and cholesterol, triglyceride, glucose, and glucose/triglycerides index values at the end of the study. A modified intention-to-treat analysis was performed through linear regression models and using the Bonferroni method to penalized p-values by multiple comparisons. Results: Twenty-three animals completed the study. There was a significant average difference in weight gain, with a greater reduction in the S2 + OVX group compared to the OVX group (difference= −3.5; 95% CI (–5.27; −1.74); p <.001). S2 + OVX group also displayed a significant average reduction of total blood cholesterol (difference: −16.94; 95% CI (–33.73; −0.15); p =.037). No significant effects of the supplement were found on other secondary endpoints. Conclusion: In this murine menopausal model, triple oral supplement dose resulted in an average reduction of weight gain and total cholesterol levels, suggesting that the compound could have a potential effect at regulating menopausal altered metabolism. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Taylor and Francis |
|
dc.relation.ispartofseries |
Gynecological Endocrinology |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Lepidium Meyenii |
en_US |
dc.subject |
supplementation |
en_US |
dc.subject |
glucosinolates |
en_US |
dc.subject |
phytosterol |
en_US |
dc.subject |
citrus flavonoids |
en_US |
dc.subject |
menopause |
en_US |
dc.subject |
body weight |
en_US |
dc.subject |
metabolism |
en_US |
dc.title |
Effect of a natural supplement containing glucosinolates, phytosterols and citrus flavonoids on body weight and metabolic parameters in a menopausal murine model induced by bilateral ovariectomy |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1080/09513590.2020.1821639 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.18 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.02 |
|
dc.relation.issn |
1473-0766 |
|